Beranda › Leukemia Mieloid Akut › Washington › Tacoma
Uji klinis Leukemia Mieloid Akut di Tacoma, WA
3 studi untuk Leukemia Mieloid Akut mencari peserta di lokasi sekitar Tacoma (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Providence Regional Cancer System-Lacey, Lacey · 23 mi jauhnya
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Menerima pesertaFase 3
- Mary Bridge Children's Hospital and Health Center, Tacoma
- Madigan Army Medical Center, Tacoma
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Menerima pesertaFase 1/2
- Mary Bridge Children's Hospital and Health Center, Tacoma
- Madigan Army Medical Center, Tacoma
Uji klinis Leukemia Mieloid Akut di kota lain
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Seattle, WA41 studi
- Baldwin Park, CA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA31 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
Studi lain di Tacoma
- Kanker Paru Non-Sel Kecil20 studi
- Kanker Payudara18 studi
- Kolitis Ulseratif15 studi
- Mieloma Multipel13 studi
- Kanker Prostat11 studi
- Penyakit Crohn11 studi
- Kanker Kolorektal9 studi
- Kanker Metastatik9 studi
- Melanoma7 studi
- Kanker Ovarium7 studi
- Kanker Lambung6 studi
- Kanker Esofagus6 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.